|
|
We Have Recently Made Changes to Our Website, If you are unable to find something Specific, Please Search Below
Publish Date : 9/9/2004 3:22:00 PM Source : SkinCareIndia Health News A program that targets allergens and tobacco smoke in the home resulted in fewer asthma symptoms in children participating in the intervention than in those who were not.
According to a new study sponsored by the National Institutes of Health (NIH) in seven metropolitan areas nationwide. Children taking part in the intervention had 21 fewer days of asthma symptoms over the one-year course of intervention. The study--co-funded by the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute of Environmental Health Sciences (NIEHS), two NIH Institutes--appears in the September 9th issue of The New England Journal of Medicine. "The burden that childhood asthma places on our society is enormous," says Anthony S. Fauci, M.D., director of NIAID. "For the millions of children living with asthma, this important research demonstrates that taking practical steps can achieve long-term benefits in the form of better quality of life, fewer emergency room visits and lower healthcare costs." "These study results are exciting because they show that changes made in the home environment can produce a reduction in symptoms comparable to that achieved with asthma inhalers," notes Kenneth Olden, Ph.D., director of NIEHS. Asthma, a chronic lung disease characterized by coughing, wheezing and difficulty breathing, affects roughly 20 million Americans. Children who live in the inner city--in particular African-American and Hispanic children--suffer disproportionately from the disease. Increased asthma symptoms in this population may stem from exposure to high levels of multiple indoor allergens and tobacco smoke. More than 900 children ages 5 to 11 with moderate to severe asthma participated in the study. Each participant had to be allergic to at least one common indoor environmental allergen, such as cockroach allergen or house dust mite allergen. The children, most of whom were African American or Hispanic, lived in low-income sections of seven major metropolitan areas--the Bronx, Boston, Chicago, Dallas, Manhattan, Seattle/Tacoma and Tucson. Once accepted into the study, they were randomly assigned to either the intervention group or a control group. Based on the child's sensitivity to the selected indoor allergens and evidence of exposures at home to known asthma triggers, investigators designed an individualized environmental intervention, carried out by the child's mother or another caretaker. The intervention focused on educating the family about ways to reduce or eliminate all allergens to which the child was allergic, as well as to reduce exposure to tobacco smoke, and motivating them to pursue these steps. The investigators developed separate interventions tailored to tobacco smoke and to the following allergens--house dust mite, cockroach, pet, rodent and mold. In addition, families were given specific allergen-reducing measures, such as allergen-impermeable covers for children's bedding and air purifiers with HEPA (high efficiency particulate air) filters, to be placed in key locations within their homes, including the children's bedrooms. Cockroach extermination visits were provided for children who were allergic to cockroach allergens. During the first year of the study, the investigators conducted educational home visits with the families in the intervention group. Throughout the yearlong study and the one-year follow-up, researchers closely monitored all participants' asthma symptoms and home allergen levels. Children who participated in the intervention had significantly fewer asthma symptoms compared with those in the control group: an average of 21 fewer days of symptoms in the first year and an average of 16 fewer days during the second, or follow-up, year. In addition, the benefits of the intervention occurred rapidly: Investigators noted significant reductions in symptoms just 2 months after the study began. The levels of cockroach and dust mite allergens in the children's bedrooms in the intervention group were substantially lower than in the control group. Furthermore, the researchers noted a direct correlation between allergen levels and asthma symptoms for the children in the intervention group: The greater the drop in cockroach or house dust mite allergen levels, the greater the reduction in asthma symptoms, suggesting that the allergy-reducing measures made the difference. Most previous environmental intervention studies focused on controlling a single allergen or tobacco smoke, and met with limited success. "Children with asthma are usually sensitive to more than one allergen," says Daniel Rotrosen, M.D., director of NIAID's Division of Allergy, Immunology, and Transplantation. "By taking a multifaceted, home-based approach, this new study demonstrates the promising results families can achieve when they incorporate the recommended practices of allergen reduction into their everyday lives." This project is part of the Inner City Asthma Study, a cooperative multicenter initiative comprising seven asthma study centers across the country and a statistical center. The principal investigators are Wayne J. Morgan, M.D., University of Arizona College of Medicine, Tucson, first author on the paper; Ellen F. Crain, M.D., Ph.D., Albert Einstein College of Medicine/Jacobi Medical Center, Bronx, NY; Richard Evans III, M.D., Children's Memorial Hospital, Chicago, IL; Rebecca S. Gruchalla, M.D., Ph.D., University of Texas Southwestern Medical Center at Dallas, TX; Meyer Kattan, M.D., Mount Sinai School of Medicine, New York, NY; Herman Mitchell, Ph.D., Rho, Inc., Chapel Hill, NC; George T. O'Connor, M.D., Boston University School of Medicine, Boston, MA; and James Stout, M.D., University of Washington School of Medicine and Public Health, Seattle, WA. NIAID and NIEHS are components of the National Institutes of Health, an agency of the U.S. Department of Health and Human Services. NIAID supports basic and applied research to prevent, diagnose and treat infectious diseases such as HIV/AIDS and other sexually transmitted infections, influenza, tuberculosis, malaria and illness from potential agents of bioterrorism. NIAID also supports research on transplantation and immune-related illnesses, including autoimmune disorders, asthma and allergies. NIEHS conducts and supports research to reduce the burden of human illness and dysfunction from environmental causes by understanding environmental factors, individual susceptibility and age, and by discovering how these influences interrelate. Reference: W Morgan et al. Results of a home-based environmental intervention in urban children with asthma--The Inner City Asthma Study. The New England Journal of Medicine 351(11):1068-80 (2004). News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov. |
|
Cervical cancer vaccine breakthrough
Publish Date : 11/15/2004 1:16:00 PM Scientists say they have tested a vaccine, Cervarix, that protects women from two strains of HPV (human papillomavirus) which are responsible for 70% of cervical cancers. Beyond Tactical Struggles over Public Policy -The President's Council on Bioethics Publish Date : 11/15/2004 1:15:00 PM An on-stage discussion with William F May, PhD. Bioethicist and Author Human mad cow disease, there are many different forms of it Publish Date : 11/15/2004 1:15:00 PM Depending on your genetic makeup, vCJD (Varian Mad Cow Disease) will manifest itself differently, say researchers. This means vCJD may be present in some areas without being detected (vCJD means the human form of mad cow disease). New online tool kit on HIV/AIDS prevention for sex workers Publish Date : 11/15/2004 1:11:00 PM GTZ, WHO and sex work networks share information and lessons learned - The German technical cooperation (GTZ) and the World Health Organization (WHO), in collaboration with sex work networks around the world..... Anti-drug driving campaign wins award Publish Date : 11/10/2004 7:34:00 PM A road safety initiative to stop people driving under the influence of drugs has won an award at the THINK road safety conference. Text Messaging Helps Patients in Developing Countries Manage HIV/AIDS Treatment Publish Date : 11/10/2004 7:33:00 PM Wired News on Thursday examined how HIV/AIDS treatment counselors in countries where health care .... Roche Diagnostics Launches Highly-sensitive Polymerase Chain Reaction System Publish Date : 11/10/2004 7:32:00 PM Roche Diagnositcs has begun sales of it's real-time polymerase chain reaction (PCR) system LightCycler ST300, a highly-sensitive gene analysis system. 3 by 5 Initiative for HIV 'Probably Will Not' Meet Treatment Publish Date : 11/10/2004 7:31:00 PM The World Health Organization's 3 by 5 Initiative goal of treating three million HIV-positive people with antiretroviral ........ Manufacturing Approval for Statmark Influenza Virus Detection Reagent Publish Date : 11/10/2004 7:30:00 PM Nichirei (TSe: 2871), a leading Japanese food processing company, has announced that it has ..... US Health Improvements Slowing - Alarm at High Infant Mortality Rates and Obesity Publish Date : 11/10/2004 7:28:00 PM Although the overall health of US residents continues to improve, health indicators show that ... Total Results : 3044 More News (Opens in New Window) : [1] 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 Next Page |
|